Welcome to Business of Cannabis’ new weekly strategic digest tracking the financial health, market moves, and corporate developments shaping the
Denmark has officially passed legislation which will solidify its long-running medical cannabis pilot programme as a permanent fixture of its national healthcare system in what has been described as a ‘victory for patients’.
UK-listed medical cannabis producer Celadon Pharmaceuticals is struggling to emerge from its precarious financial position after months of turmoil.
Celadon Pharmaceuticals Celadon Pharmaceuticals has seen its stock price spike this week after revealing that its supply agreement with
Argent Biopharma Argent Biopharma (previously MGC Pharmaceuticals), the first company in history to launch an IPO on the London
Denmark’s six-year medical cannabis pilot scheme could soon be expanded into a fully legalised market, following a surprise announcement from the government last week.
Cannabis stocks plunge on election results As the outcome of the US presidential election and numerous state-specific cannabis ballots dripped
DanCann Pharma Danish cannabis company DanCann Pharma has announced plans to enact a reverse stock split aimed at ‘stabilising
Jazz Pharmaceuticals The pharmaceutical giant announced last week that its flagship cannabinoid treatment, Epidyolex, failed to pass its Phase
Akanda Corp Akanda Corp has announced plans to implement another reverse stock split, its second to date, following a
We won’t spam you
© 2024 Prohibition Holdings Ltd. All Rights Reserved.
